Search Results - Guangan Hu
- Showing 1 - 5 results of 5
-
1
-
2
1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models by Yi Xu, Dong Zhang, Nan Bing, Hong Chang, Sheng Yin, Guangan Hu, Quanju Zhao, Xiaochun Chen, Xiaodong Jiang
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
3
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis by Ting Dong, Guangan Hu, Zhongqi Fan, Huirui Wang, Yinghui Gao, Sisi Wang, Hao Xu, Michael B. Yaffe, Matthew G. Vander Heiden, Guoyue Lv, Jianzhu Chen
Published in Nature Communications (2024-01-01)Get full text
Article -
4
IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy by Li Pan, Kin-Sang Cho, Xin Wei, Fuyi Xu, Anton Lennikov, Guangan Hu, Jing Tang, Shuai Guo, Julie Chen, Emil Kriukov, Robert Kyle, Farris Elzaridi, Shuhong Jiang, Pierre A. Dromel, Michael Young, Petr Baranov, Chi-Wai Do, Robert W. Williams, Jianzhu Chen, Lu Lu, Dong Feng Chen
Published in Cell Reports (2023-08-01)Get full text
Article -
5
LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation by Muchaala Yeboah, Charys Papagregoriou, Des C. Jones, H.T. Claude Chan, Guangan Hu, Justine S. McPartlan, Torbjörn Schiött, Ulrika Mattson, C. Ian Mockridge, Ulla-Carin Tornberg, Björn Hambe, Anne Ljungars, Mikael Mattsson, Ivo Tews, Martin J. Glennie, Stephen M. Thirdborough, John Trowsdale, Björn Frendeus, Jianzhu Chen, Mark S. Cragg, Ali Roghanian
Published in JCI Insight (2020-09-01)Get full text
Article